Literature DB >> 20004511

Epidemiological and clinical features of Moyamoya disease in Nanjing, China.

Wei Miao1, Peng-Lai Zhao, Yan-Song Zhang, Hong-Yi Liu, Yi Chang, Jun Ma, Qing-Jiu Huang, Zheng-Xiang Lou.   

Abstract

OBJECTIVE: The epidemiology of Moyamoya disease in mainland China has not been documented. Therefore, the present study was designed to examine the epidemiological and clinical features of Moyamoya disease in Nanjing, a provincial capital in China.
METHODS: Patient records from multiple hospitals in Nanjing from January 2000 to December 2007 were collected. The clinical features of Moyamoya disease were retrospectively analyzed.
RESULTS: A total of 202 patients were identified. There were 94 males and 108 females, with ages ranging from 2 to 78 years. There was a dual age peak, one in the group of patients 5-9 years of age and another in the group of patients 35-39 years of age. The initial symptoms included cerebral ischemia (81 patients, 40%), cerebral hemorrhage (113 patients, 55.9%) and asymptomatic disease (8 patients, 3.9%). An increasing incidence rate of Moyamoya disease was observed during the period of 2000-2007, with an average detection rate of 0.43cases/100,000 persons/year (prevalence 3.92/100,000 persons). The incidence of ischemia associated with the disease was 0.16cases/100,000 people-years and the incidence of hemorrhage was 0.22cases/100,000 people-years.
CONCLUSION: This first study on the epidemiological and clinical features of Moyamoya disease in mainland China indicated an increasing incidence of Moyamoya disease with bimodal incidence distribution appearing more frequently in adults.

Entities:  

Mesh:

Year:  2009        PMID: 20004511     DOI: 10.1016/j.clineuro.2009.11.009

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  36 in total

1.  Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population.

Authors:  Yang Cao; Hatasu Kobayashi; Takaaki Morimoto; Risako Kabata; Kouji H Harada; Akio Koizumi
Journal:  Environ Health Prev Med       Date:  2016-06-30       Impact factor: 3.674

2.  Missing relationship of moyamoya and persistent primitive artery in Europeans. Another distinctive feature or artifact?

Authors:  Holger Wenz; Ralf Wenz; Alex Förster; Johann Fontana; Hans Ulrich Kerl; Christoph Groden; Johann Scharf
Journal:  Surg Radiol Anat       Date:  2015-03-08       Impact factor: 1.246

3.  Pregnancy and delivery in moyamoya vasculopathy: experience of a single European institution.

Authors:  Güliz Acker; Marcus Czabanka; Peter Schmiedek; Peter Vajkoczy
Journal:  Neurosurg Rev       Date:  2017-09-18       Impact factor: 3.042

Review 4.  Progress in moyamoya disease.

Authors:  Shuling Shang; Da Zhou; Jingyuan Ya; Sijie Li; Qi Yang; Yuchuan Ding; Xunming Ji; Ran Meng
Journal:  Neurosurg Rev       Date:  2018-06-18       Impact factor: 3.042

5.  Structural abnormalities in paediatric moyamoya disease revealed by clinical magnetic resonance imaging, regionally distributed relative signal intensities and volumes.

Authors:  Prahar Ijner; Grace Tompkins; Tadashi Shiohama; Emi Takahashi; Jacob Levman
Journal:  Int J Dev Neurosci       Date:  2022-01-13       Impact factor: 2.457

6.  Prevalence and epidemiological features of moyamoya disease in Korea.

Authors:  Sang Hyuk Im; Sang Hyuk Yim; Chul Bum Cho; Won Il Joo; Chung Kee Chough; Hae Kwan Park; Kyung Jin Lee; Hyoung Kyun Rha
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2012-06-30

7.  Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development.

Authors:  Wanyang Liu; Daisuke Morito; Seiji Takashima; Yohei Mineharu; Hatasu Kobayashi; Toshiaki Hitomi; Hirokuni Hashikata; Norio Matsuura; Satoru Yamazaki; Atsushi Toyoda; Ken-ichiro Kikuta; Yasushi Takagi; Kouji H Harada; Asao Fujiyama; Roman Herzig; Boris Krischek; Liping Zou; Jeong Eun Kim; Masafumi Kitakaze; Susumu Miyamoto; Kazuhiro Nagata; Nobuo Hashimoto; Akio Koizumi
Journal:  PLoS One       Date:  2011-07-20       Impact factor: 3.240

8.  Clinical and immunopathological features of Moyamoya disease.

Authors:  Runhua Lin; Zeyu Xie; Jianfa Zhang; Hongwu Xu; Hang Su; Xuerui Tan; Dongping Tian; Min Su
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

9.  Clinical Significance of Ultrasound-Based Hemodynamic Assessment of Extracranial Internal Carotid Artery and Posterior Cerebral Artery in Symptomatic and Angiographic Evolution of Moyamoya Disease: A Preliminary Study.

Authors:  Shuai Zheng; Peicong Ge; Zhiyong Shi; Jingzhe Wang; Yi Li; Tengfei Yu; Jinghan Zhang; Hongxia Zhang; Dong Zhang; Wen He
Journal:  Front Neurol       Date:  2021-05-17       Impact factor: 4.003

10.  Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population.

Authors:  Zhiyuan Wu; Hanqiang Jiang; Lei Zhang; Xiao Xu; Xinju Zhang; Zhihua Kang; Donglei Song; Jin Zhang; Ming Guan; Yuxiang Gu
Journal:  PLoS One       Date:  2012-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.